Showing results (1471-1480 of 1,682) with videos related to

Sort By:
Pageof 169
Journal of Experimental & Clinical Cancer Research : CR|January 10, 2024
Marinopyrrole derivative MP1 as a novel anti-cancer agent in group 3 MYC-amplified MedulloblastomaDon W Coulter, Yashpal S Chhonker, Devendra Kumar, et al.
Oncogene|April 6, 2026
TAK1 is a key regulator of oncogenic signaling and differentiation blockade in rhabdomyosarcomaAnh Tuan Vuong, Aniket S Joshi, Anirban Roy, et al.
Circulation. Cardiovascular Imaging|October 15, 2024
Current and Emerging Radiotracers in Molecular Cardiovascular ImagingShruti S Joshi, Jolien Geers, Alessia Gimelli, et al.
BJU International|May 31, 2019
Prediction of significant estimated glomerular filtration rate decline after renal unit removal to aid in the clinical choice between radical and partial nephrectomy in patients with a renal mass and normal renal functionAndrew G McIntosh, Daniel C Parker, Brian L Egleston, et al.
American Journal of Physiology. Renal Physiology|October 24, 2024
Sex differences in the adrenal circadian clock: a role for BMAL1 in the regulation of urinary aldosterone excretion and renal electrolyte balance in miceHannah M Costello, Sophia A Eikenberry, Kit-Yan Cheng, et al.
Cancer|October 7, 2023
2018 Leibovich prognostic model for renal cell carcinoma: Performance in a large population with special consideration of Black raceBenjamin N Schmeusser, Dattatraya H Patil, Edouard H Nicaise, et al.
Plos One|June 24, 2025
The Healthy Brain 9 (HB9): A new instrument to characterize subjective cognitive decline, and detect anosognosia in mild cognitive impairmentJames E Galvin, Katherine C Almonte, Andrea Buehler, et al.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2025
The Healthy Brain 9 (HB9): A New Instrument to Characterize Subjective Cognitive Decline, and Detect Anosognosia in Mild Cognitive ImpairmentJames E Galvin, Katherine C Almonte, Andrea Buehler, et al.
Molecular Carcinogenesis|December 28, 2017
Suppression of STAT3 NH<sub>2</sub> -terminal domain chemosensitizes medulloblastoma cells by activation of protein inhibitor of activated STAT3 via de-repression by microRNA-21Sutapa Ray, Don W Coulter, Shawn D Gray, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 22, 2018
Barriers to screening and isoniazid preventive therapy for child contacts of tuberculosis patientsV Belgaumkar, A Chandanwale, C Valvi, et al.
Pageof 169